BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu LX, Della-torre E, Stone JH, Clark SW. IgG4-Related Hypertrophic Pachymeningitis: Clinical Features, Diagnostic Criteria, and Treatment. JAMA Neurol 2014;71:785. [DOI: 10.1001/jamaneurol.2014.243] [Cited by in Crossref: 133] [Cited by in F6Publishing: 96] [Article Influence: 16.6] [Reference Citation Analysis]
Number Citing Articles
1 Katabathina VS, Khalil S, Shin S, Lath N, Menias CO, Prasad SR. Immunoglobulin G4-Related Disease: Recent Advances in Pathogenesis and Imaging Findings. Radiol Clin North Am 2016;54:535-51. [PMID: 27153787 DOI: 10.1016/j.rcl.2015.12.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
2 Wadiwala MF, Ali L, Khan A, Alhatou M. The great imposter: A case report of IgG4‐RD hypertrophic pachymeningitis with skull lytic lesion and pulmonary nodules. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5470] [Reference Citation Analysis]
3 Wong VC, Yung G, Russo R, Reddel SW, Mansberg R. Pachymeningitis Demonstrated on Gallium SPECT/CT Scan. Clin Nucl Med 2019;44:305-9. [PMID: 30762818 DOI: 10.1097/RLU.0000000000002484] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Peng A, Yang X, Wu W, Xiao Z, Xie D, Ge S. Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media: a review of literature. Eur Arch Otorhinolaryngol 2018;275:2915-23. [PMID: 30328500 DOI: 10.1007/s00405-018-5172-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Yamamuro S, Negishi H, Shijo K, Yoshino A. Treatment-responsive case of focal clivus IgG4-related hypertrophic pachymeningitis mimicking meningioma; case report. Acta Neurol Belg 2021;121:1395-7. [PMID: 33834426 DOI: 10.1007/s13760-021-01667-5] [Reference Citation Analysis]
6 Kon T, Nishijima H, Haga R, Funamizu Y, Ueno T, Arai A, Suzuki C, Nunomura J, Baba M, Takahashi T, Tomiyama M. Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: A case report. J Neuroimmunol 2015;287:27-8. [PMID: 26439957 DOI: 10.1016/j.jneuroim.2015.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Goglin S, Cho TA. Clinical approach to neuro-rheumatology. J Neurol Sci 2021;431:120048. [PMID: 34768134 DOI: 10.1016/j.jns.2021.120048] [Reference Citation Analysis]
8 Löhr JM, Beuers U, Vujasinovic M, Alvaro D, Frøkjær JB, Buttgereit F, Capurso G, Culver EL, de-Madaria E, Della-Torre E, Detlefsen S, Dominguez-Muñoz E, Czubkowski P, Ewald N, Frulloni L, Gubergrits N, Duman DG, Hackert T, Iglesias-Garcia J, Kartalis N, Laghi A, Lammert F, Lindgren F, Okhlobystin A, Oracz G, Parniczky A, Mucelli RMP, Rebours V, Rosendahl J, Schleinitz N, Schneider A, van Bommel EF, Verbeke CS, Vullierme MP, Witt H; UEG guideline working group. European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J 2020;8:637-66. [PMID: 32552502 DOI: 10.1177/2050640620934911] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 26.5] [Reference Citation Analysis]
9 Huang K, Xu Q, Ma Y, Zhan R, Shen J, Pan J. Cerebral Venous Sinus Thrombosis Secondary to Idiopathic Hypertrophic Cranial Pachymeningitis: Case Report and Review of Literature. World Neurosurg 2017;106:1052.e13-21. [PMID: 28711538 DOI: 10.1016/j.wneu.2017.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
10 Sireesha Y, Uppin MS, Ganti S, Alugolu R, Mudumba VS, Bhattacharjee S, Neeharika ML, Bastia J, Kanikannan MA. A Series of Biopsy-proven Patients with Immunoglobulin G4-related Neurological Disease. Ann Indian Acad Neurol 2019;22:73-8. [PMID: 30692763 DOI: 10.4103/aian.AIAN_283_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dash GK, Thomas B, Nair M, Radhakrishnan A. Clinico-radiological spectrum and outcome in idiopathic hypertrophic pachymeningitis. J Neurol Sci 2015;350:51-60. [PMID: 25703277 DOI: 10.1016/j.jns.2015.02.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
12 Waheed W, Skidd PM, Borden NM, Gibson PC, Babi MA, Tandan R. Metachronous Involvement, Diagnostic Imprecision of Serum Immunoglobulin G4 Levels, and Discordance Between Clinical and Radiological Findings in Immunoglobulin G4–Related Pachymeningitis: A Longitudinal Case Report. JCR: Journal of Clinical Rheumatology 2017;23:215-21. [DOI: 10.1097/rhu.0000000000000488] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Vakrakou AG, Evangelopoulos ME, Boutzios G, Tzanetakos D, Tzartos J, Velonakis G, Toulas P, Anagnostouli M, Andreadou E, Koutsis G, Stefanis L, Fragoulis GE, Kilidireas C. Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review. Rheumatol Int 2020;40:337-43. [PMID: 31898763 DOI: 10.1007/s00296-019-04502-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hiraga A, Ozaki D, Tsuneyama A, Ito S, Koide K, Kuwabara S. Corticosteroid-responsive leptomeningitis with IgG4-positive plasma-cell infiltration. J Neurol Sci 2015;357:338-40. [PMID: 26254623 DOI: 10.1016/j.jns.2015.07.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
15 Xie L, Liu T, Yao H, Wu L, Qiu W, Chen B, Liu S, Huang Q, Yang H, Xu H, Long Y, Gao C. Autoimmune inflammatory meningoencephalitis in a patient negative for glial fibrillary acidic protein-specific immunoglobulin G. Mult Scler Relat Disord 2019;28:167-71. [PMID: 30605794 DOI: 10.1016/j.msard.2018.12.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Cilliers JD, Eindhoven SC, Louw E, Koegelenberg CFN, Irusen E, Bruce-Brand C, Allwood BW. Pulmonary manifestations of IgG4‑related disease in a South African patient. Afr J Thorac Crit Care Med 2021;27. [PMID: 34240046 DOI: 10.7196/AJTCCM.2021.v27i1.130] [Reference Citation Analysis]
17 Ishikawa Y, Miyagawa I, Nakano K, Satoh Y, Todoroki Y, Kubo S, Nawata A, Nakayamada S, Saito K, Tanaka Y. The occurrence of hypertrophic pachymeningitis with infiltration of IgG4-positive plasma cells and with different aetiology: report of three cases. Modern Rheumatology Case Reports 2017;1:108-12. [DOI: 10.1080/24725625.2017.1307162] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Della-Torre E, Campochiaro C, Cassione EB, Albano L, Gerevini S, Bianchi-Marzoli S, Bozzolo E, Passerini G, Lanzillotta M, Terreni M, Callea M, Trimarchi M, Mortini P, Tresoldi M, Acerno S, Dagna L. Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis. J Neurol Neurosurg Psychiatry 2018;89:441-4. [PMID: 28819060 DOI: 10.1136/jnnp-2017-316519] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
19 Hwang G, Jin S, Kim H. IgG4-related disease presenting as hypertrophic pachymeningitis and compressive optic neuropathy. Joint Bone Spine 2016;83:601-2. [DOI: 10.1016/j.jbspin.2015.07.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
20 Schubert RD, Wood M, Levin MH, Perry A, Gelfand JM. The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum. Neurol Neuroimmunol Neuroinflamm 2016;3:e197. [PMID: 26770998 DOI: 10.1212/NXI.0000000000000197] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Baptista B, Casian A, Gunawardena H, D'Cruz D, Rice CM. Neurological Manifestations of IgG4-Related Disease. Curr Treat Options Neurol 2017;19:14. [PMID: 28374231 DOI: 10.1007/s11940-017-0450-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
22 Bridges KJ, DeDeaux CH, Than KD. IgG4-related disease presenting as intradural extramedullary lesion: a case report and review of the literature. Br J Neurosurg 2019;33:570-6. [PMID: 28958166 DOI: 10.1080/02688697.2017.1384793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Slade SJ, Bauer EM, Stone VV, Dave AJ. Spinal IgG4-Related Hypertrophic Pachymeningitis with Spinal Cord Compression: Case Report and Literature Review. World Neurosurgery 2019;130:65-70. [DOI: 10.1016/j.wneu.2019.06.130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Kuranari Y, Tamura R, Mikami S, Ohara K, Toda M, Yoshida K. Severe headache in a patient with meningioma showing extensive dural tail correlates with IgG4-positive plasma cells and eosinophils: A case report and review of literature. Surg Neurol Int 2018;9:202. [PMID: 30386672 DOI: 10.4103/sni.sni_231_18] [Reference Citation Analysis]
25 Fujimoto S, Kim CH, Green T, Xu H. Otologic Manifestations of Immunoglobulin G4-Related Disease. Ear Nose Throat J 2019;98:630-1. [PMID: 30987463 DOI: 10.1177/0145561319842852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Williams T, Marta M, Giovannoni G. IgG4-related disease: a rare but treatable cause of refractory intracranial hypertension. Pract Neurol 2016;16:235-9. [DOI: 10.1136/practneurol-2015-001275] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
27 Ichikawa S, Onishi H. Imaging findings of immunoglobulin G4-related disease: from the head to the pelvis. Singapore Med J 2021;62:574-81. [PMID: 35001118 DOI: 10.11622/smedj.2021226] [Reference Citation Analysis]
28 Maamri K, Taieb MAH, Elkahla G, Hadhri R, Dermoul M. Immunoglobulin G4-related disease presenting as an intracranial mass extended from the infratemporal fossa. Surg Neurol Int 2022;13:224. [PMID: 35673662 DOI: 10.25259/SNI_149_2022] [Reference Citation Analysis]
29 Maher M, Zanazzi G, Faust P, Nickerson K, T. Wong T. IgG4-related hypertrophic pachymeningitis of the spine with MPO-ANCA seropositivity. Clinical Imaging 2017;46:108-12. [DOI: 10.1016/j.clinimag.2017.07.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
30 Ezzeldin M, Shawagfeh A, Schnadig V, Smith RG, Fang X. Hypertrophic spinal pachymeningitis: Idiopathic vs. IgG4-related. Journal of the Neurological Sciences 2014;347:398-400. [DOI: 10.1016/j.jns.2014.10.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
31 Soares C, Martins DF, Pestana-silva R, Honavar M, Faria O, Abreu P, Costa A. Intrathecal rituximab in immunoglobulin G4-hypertrophic pachymeningitis. Journal of Neuroimmunology 2019;334:576997. [DOI: 10.1016/j.jneuroim.2019.576997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Seegobin K, Moustafa MA, Gannon N, Keller K, Hastings J, Gupta V, Tun HW, Jiang L. Successful treatment of IgG4-related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab. Clin Case Rep 2021;9:1610-4. [PMID: 33768900 DOI: 10.1002/ccr3.3855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Gomathy S, Elavarasi A, Komakula S, Modi M, Sharma M, Kaur K, Garg A, Tripathi M, Kanodia A, Verma H, Vibha D, Singh RK, Ramanujam B, Tripathi M. A case of multiple cranial nerve palsies. Pract Neurol 2021;21:523-31. [DOI: 10.1136/practneurol-2021-003069] [Reference Citation Analysis]
34 Lanzillotta M, Fernàndez-Codina A, Culver E, Ebbo M, Martinez-Valle F, Schleinitz N, Della-Torre E. Emerging therapy options for IgG4-related disease. Expert Rev Clin Immunol 2021;17:471-83. [PMID: 33689549 DOI: 10.1080/1744666X.2021.1902310] [Reference Citation Analysis]
35 Margolin EA, Gopwani J, Eberhart CG, Blitz AM. Mass confusion in a 30-year-old man. J Neuroophthalmol 2014;34:408-11. [PMID: 25405663 DOI: 10.1097/WNO.0000000000000194] [Reference Citation Analysis]
36 Parsons AM, Aslam F, Grill MF, Aksamit AJ, Goodman BP. Rheumatoid Meningitis: Clinical Characteristics, Diagnostic Evaluation, and Treatment. Neurohospitalist 2020;10:88-94. [PMID: 32373270 DOI: 10.1177/1941874419859769] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
37 Dillon J, Dart A, Sutherland T. Imaging features of immunoglobulin G4-related disease. J Med Imaging Radiat Oncol 2016;60:707-13. [PMID: 27562417 DOI: 10.1111/1754-9485.12511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Amin M, Purohit M, Calabrese C, Prayson R, Li Y. Hypertrophic Pachymeningitis and Choroid Plexitis in IgG-4-Related Disease. Neurol Clin Pract 2021;11:e570-2. [PMID: 34484962 DOI: 10.1212/CPJ.0000000000000981] [Reference Citation Analysis]
39 Rubin DB, Batra A, Vaitkevicius H, Vodopivec I. Autoimmune Neurologic Disorders. The American Journal of Medicine 2018;131:226-36. [DOI: 10.1016/j.amjmed.2017.10.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
40 Brito-Zerón P, Ramos-Casals M, Bosch X, Stone JH. The clinical spectrum of IgG4-related disease. Autoimmun Rev. 2014;13:1203-1210. [PMID: 25151972 DOI: 10.1016/j.autrev.2014.08.013] [Cited by in Crossref: 169] [Cited by in F6Publishing: 140] [Article Influence: 21.1] [Reference Citation Analysis]
41 Russo A, Silvestro M, Cirillo M, Tessitore A, Tedeschi G. Idiopathic hypertrophic pachymeningitis mimicking hemicrania continua: An unusual clinical case. Cephalalgia 2018;38:804-7. [PMID: 28474987 DOI: 10.1177/0333102417708773] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
42 Matsumoto N, Hishikawa N, Ikegami K, Sato K, Omote Y, Takemoto M, Yamashita T, Taniguchi K, Abe K. A Unique Case of Encephalopathy with an Elevated IgG-4 and Extremely High Interleukin-6 Level and Delayed Myelodysplastic Syndrome. Intern Med 2021;60:2125-8. [PMID: 33390491 DOI: 10.2169/internalmedicine.6098-20] [Reference Citation Analysis]
43 Della-Torre E, Bozzalla-Cassione E, Sciorati C, Ruggiero E, Lanzillotta M, Bonfiglio S, Mattoo H, Perugino CA, Bozzolo E, Rovati L, Arcidiacono PG, Balzano G, Lazarevic D, Bonini C, Falconi M, Stone JH, Dagna L, Pillai S, Manfredi AA. A CD8α- Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment. Arthritis Rheumatol 2018;70:1133-43. [PMID: 29499100 DOI: 10.1002/art.40469] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
44 Mekinian A, Maisonobe L, Boukari L, Melenotte C, Terrier B, Ayrignac X, Schleinitz N, Sène D, Hamidou M, Konaté A, Guilpain P, Abisror N, Ghrenassia E, Lachenal F, Cevallos R, Roos-Weil R, Du LTH, Lhote F, Larroche C, Bergmann JF, Humbert S, Fraison JB, Piette JC, Guillevin L, Dhote R, Amoura Z, Haroche J, Fain O. Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patients. Medicine (Baltimore) 2018;97:e11413. [PMID: 30045263 DOI: 10.1097/MD.0000000000011413] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
45 Fernández-codina A, Hernández-gonzález M, Solans-laquè R, Bujan-rivas S, Vilardell-tarrés M, Martínez-valle F. Alteration of IgG4 levels in cerebrospinal fluid in IgG4-related disease. Int J Rheum Dis 2017;20:1865-7. [DOI: 10.1111/1756-185x.12739] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
46 Ma W, Wang X, Nie M, Fu J, Mao J, Wu X. Two cases of immunoglobulin G4 (IgG4)-related hypophysitis diagnosed without pituitary biopsy. Ther Adv Endocrinol Metab 2020;11:2042018820924556. [PMID: 32637064 DOI: 10.1177/2042018820924556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Obiorah IE, Henao Velasquez A, Özdemirli M. The Clinicopathologic Spectrum of IgG4-Related Disease. Balkan Med J 2018;35:292-300. [PMID: 29866638 DOI: 10.4274/balkanmedj.2018.0809] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
48 Medavaram S, Xue F, Lahita R. IgG4 Syndrome Presenting as Leptomeningitis in a Young Woman. J Rheumatol 2016;43:828-9. [PMID: 27037246 DOI: 10.3899/jrheum.151236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Imbery TE, Kesser BW. Abnormal Enhancement of the Internal Auditory Canal and Petrous Apex: Possible Implication of Polysorbate 80 and Immunoglobulin-related Hypertrophic Pachymeningitis. Otology & Neurotology 2019;40:e852-3. [DOI: 10.1097/mao.0000000000002350] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Kosumi Y, Nakamura H, Watanabe R, Watanabe T, Horita T. Glossopharyngeal/vagus nerve disorder due to IgG4-related hypertrophic pachymeningitis. Rheumatology (Oxford) 2019. [PMID: 30715454 DOI: 10.1093/rheumatology/kez009] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Yu Y, Lv L, Yin SL, Chen C, Jiang S, Zhou PZ. Clivus-involved immunoglobulin G4 related hypertrophic pachymeningitis mimicking meningioma: A case report. World J Clin Cases 2022; 10(18): 6269-6276 [DOI: 10.12998/wjcc.v10.i18.6269] [Reference Citation Analysis]
52 Thakur KT, Wilson MR. Chronic Meningitis. Continuum (Minneap Minn) 2018;24:1298-326. [PMID: 30273241 DOI: 10.1212/CON.0000000000000664] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Wyrostek S, Chakrabarti S, Baldwin K, Avila JD. A Case of Hypertrophic Pachymeningitis Associated with Immunoglobulin-G4 and c-ANCA. Case Rep Neurol 2019;11:290-4. [PMID: 31762760 DOI: 10.1159/000502569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ 2020;369:m1067. [PMID: 32546500 DOI: 10.1136/bmj.m1067] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
55 Marlin ES, Dornbos D 3rd, Ikeda DS, Lehman NL, Powers CJ. IgG4-Related Disease: A New Etiology Underlying Diffuse Intracranial Dilating Vasculopathy. World Neurosurg 2017;107:1048.e15-20. [PMID: 28803167 DOI: 10.1016/j.wneu.2017.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
56 Scheitel M, Ives ST, Nasr R, Nolan MW. When the plot thickens: a rare complication of rheumatoid arthritis. J Community Hosp Intern Med Perspect 2019;9:143-6. [PMID: 31044046 DOI: 10.1080/20009666.2019.1593780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
57 Safi SS, Murshed K, Ali A, Vattoth S, Haider A, Al-Bozom I. Rosai-Dorfman disease of cranial and spinal origin - A case series. Surg Neurol Int 2020;11:298. [PMID: 33093975 DOI: 10.25259/SNI_391_2020] [Reference Citation Analysis]
58 Li L, Tse PY, Tsang FC, Lo RC, Lui W, Leung GK. IgG4-Related Hypertrophic Pachymeningitis at the Falx Cerebrii with Brain Parenchymal Invasion: A Case Report. World Neurosurgery 2015;84:591.e7-591.e10. [DOI: 10.1016/j.wneu.2015.03.035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
59 Navalpotro-Gómez I, Vivanco-Hidalgo RM, Cuadrado-Godia E, Medrano-Martorell S, Alameda-Quitllet F, Villalba-Martínez G, Roquer J. Focal status epilepticus as a manifestation of idiopathic hypertrophic cranial pachymeningitis. J Neurol Sci 2016;367:232-6. [PMID: 27423594 DOI: 10.1016/j.jns.2016.06.025] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Bradshaw MJ, Bhattacharyya S, Venna N, Cahill JF. Neurologic Manifestations of Systemic Rheumatologic Diseases. In: Rizvi SA, Cahill JF, Coyle PK, editors. Clinical Neuroimmunology. Cham: Springer International Publishing; 2020. pp. 321-42. [DOI: 10.1007/978-3-030-24436-1_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
61 Sbeih I, Darwazeh R, Shehadeh M, Al-Kanash R, Abu-Farsakh H, Sbeih A. Immunoglobulin G4-Related Hypertrophic Pachymeningitis of the Spine: A Case Report and Systematic Review of the Literature. World Neurosurg 2020;143:445-53. [PMID: 32777395 DOI: 10.1016/j.wneu.2020.07.227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Tang H, Ding G, Xiong J, Zhu H, Hua L, Xie Q, Gong Y. Clivus Inflammatory Pseudotumor Associated with Immunoglobulin G4-Related Disease. World Neurosurg 2018;118:71-4. [PMID: 29966794 DOI: 10.1016/j.wneu.2018.06.174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
63 Popkirov S, Kowalski T, Schlegel U, Skodda S. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab. J Clin Neurosci 2015;22:1038-40. [PMID: 25861887 DOI: 10.1016/j.jocn.2014.12.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
64 Richie MB. Autoimmune Meningitis and Encephalitis. Neurol Clin 2022;40:93-112. [PMID: 34798977 DOI: 10.1016/j.ncl.2021.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Charleston L 4th, Cooper W. An Update on Idiopathic Hypertrophic Cranial Pachymeningitis for the Headache Practitioner. Curr Pain Headache Rep 2020;24:57. [PMID: 32803475 DOI: 10.1007/s11916-020-00893-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Saint-Gerons M, Muñoz S, Bilyk JR. Hide and seek. Surv Ophthalmol 2020;65:109-15. [PMID: 30521818 DOI: 10.1016/j.survophthal.2018.11.004] [Reference Citation Analysis]
67 Cubides H, Londono J, Parra V, Saldarriaga E. Possible steroid-resistant IgG4-related pachymeningitis treated with parenteral methotrexate. Revista Colombiana de Reumatología 2017;24:112-7. [DOI: 10.1016/j.rcreu.2016.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
68 Cui Y, Masaki K, Zhang X, Yamasaki R, Fujii T, Ogata H, Hayashida S, Yamaguchi H, Hyodo F, Eto H, Koyama S, Iinuma K, Yonekawa T, Matsushita T, Yoshida M, Yamada K, Kawano M, Malissen M, Malissen B, Kira J. A novel model for treatment of hypertrophic pachymeningitis. Ann Clin Transl Neurol 2019;6:431-44. [PMID: 30911567 DOI: 10.1002/acn3.715] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
69 Goulam-Houssein S, Grenville JL, Mastrocostas K, Munoz DG, Lin A, Bharatha A, Vlachou PA. IgG4-related intracranial disease. Neuroradiol J 2019;32:29-35. [PMID: 30320530 DOI: 10.1177/1971400918806323] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
70 Yim SH, Yoon JS, Lee CH, Kim J. Hypertrophic Pachymeningitis and Interstitial Lung Disease in IgG4-Related Disease. J Clin Neurol 2022;18:481-3. [PMID: 35796274 DOI: 10.3988/jcn.2022.18.4.481] [Reference Citation Analysis]
71 Lu Z, Tongxi L, Jie L, Yujuan J, Wei J, Xia L, Yumin Z, Xin L. IgG4-related spinal pachymeningitis. Clin Rheumatol 2016;35:1549-53. [PMID: 26567899 DOI: 10.1007/s10067-015-3104-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
72 Prayson RA. Immunoglobulin G4-related ophthalmic disease presenting as uveitis. J Clin Neurosci 2015;22:1848-9. [PMID: 26188666 DOI: 10.1016/j.jocn.2015.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
73 Nakajima I, Taniguchi Y, Mizobuchi T, Kishimoto T, Fukushima A, Fukuda K. Optic Neuropathy with Headache and Palpable Temporal Arteries Due to Hypertrophic Pachymeningitis Rather than Giant Cell Arteritis. Ocul Immunol Inflamm 2021;:1-4. [PMID: 33793376 DOI: 10.1080/09273948.2021.1881561] [Reference Citation Analysis]
74 Lanzillotta M, Campochiaro C, Trimarchi M, Arrigoni G, Gerevini S, Milani R, Bozzolo E, Biafora M, Venturini E, Cicalese MP, Stone JH, Sabbadini MG, Della-Torre E. Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. Mod Rheumatol 2017;27:638-45. [PMID: 27622319 DOI: 10.1080/14397595.2016.1227026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
75 Chwalisz BK, Stone JH. Neuro-ophthalmic complications of IgG4-related disease. Curr Opin Ophthalmol 2018;29:485-94. [PMID: 30199519 DOI: 10.1097/ICU.0000000000000523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
76 Kim SH, Kim JS. Immunoglobulin G4-Related Hypertrophic Pachymeningitis Mimicking Chiari Malformation. J Clin Neurol 2016;12:238-40. [PMID: 26541498 DOI: 10.3988/jcn.2016.12.2.238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
77 Tellez R, Bromfield B, Basinger H, Slivka A. IgG4-related disease presenting with multiorgan involvement. BMJ Case Rep 2022;15:e250637. [DOI: 10.1136/bcr-2022-250637] [Reference Citation Analysis]
78 De Virgilio A, de Vincentiis M, Inghilleri M, Fabrini G, Conte M, Gallo A, Rizzo MI, Greco A. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease. Immunol Res 2017;65:386-94. [DOI: 10.1007/s12026-016-8863-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
79 Lourenço EP, Nzwalo H, Sampaio MR, Afonso L. IgG4-related disease presenting with headache and papilloedema. BMJ Case Rep 2016;2016:bcr2016216435. [PMID: 27932429 DOI: 10.1136/bcr-2016-216435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
80 Grados A, Ebbo M, Jean E, Bernit E, Harlé JR, Schleinitz N. [IgG4-related disease treatment in 2014: Update and literature review]. Rev Med Interne. 2015;36:395-404. [PMID: 25595874 DOI: 10.1016/j.revmed.2014.11.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
81 Zhang X, Fujii T, Ogata H, Yamasaki R, Masaki K, Cui Y, Matsushita T, Isobe N, Kira JI. Cerebrospinal fluid cytokine/chemokine/growth factor profiles in idiopathic hypertrophic pachymeningitis. J Neuroimmunol 2019;330:38-43. [PMID: 30784775 DOI: 10.1016/j.jneuroim.2019.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
82 Varrassi M, Gianneramo C, Arrigoni F, Cerrone P, Sucapane P, Marini C, Splendiani A. Neurological involvement of IgG4-related disease: description of a case and review of the literature. Neuroradiol J 2018;31:196-202. [PMID: 28423973 DOI: 10.1177/1971400917698173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
83 Boban J, Ardalı S, Thurnher MM. Leptomeningeal form of Immunoglobulin G4-related hypertrophic meningitis with perivascular spread: a case report and review of the literature. Neuroradiology 2018;60:769-73. [PMID: 29736618 DOI: 10.1007/s00234-018-2028-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
84 Decker ML, Emery DJ, Smyth PS, Lu J, Lacson A, Yacyshyn E. Microscopic Polyangiitis with Spinal Cord Involvement: A Case Report and Review of the Literature. Journal of Stroke and Cerebrovascular Diseases 2016;25:1696-704. [DOI: 10.1016/j.jstrokecerebrovasdis.2016.01.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
85 Bond KM, Benson JC, Cutsforth-Gregory JK, Kim DK, Diehn FE, Carr CM. Spontaneous Intracranial Hypotension: Atypical Radiologic Appearances, Imaging Mimickers, and Clinical Look-Alikes. AJNR Am J Neuroradiol 2020;41:1339-47. [PMID: 32646948 DOI: 10.3174/ajnr.A6637] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
86 Healy J, Sedarsky K, Malafronte P, Tagg NT. IgG4-related disease and intracranial hypertenstion: Case report of a novel mechanistic association. Journal of the Neurological Sciences 2018;385:75-7. [DOI: 10.1016/j.jns.2017.12.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Yeh CH, Tsui YK, Liu H, Chuang SS. Primary IgG4-producing extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in the cavernous sinus: A mimicker of IgG4-related disease/hypertrophic pachymeningitis. Pathol Int 2021;71:278-80. [PMID: 33524189 DOI: 10.1111/pin.13070] [Reference Citation Analysis]
88 Gospodarev V, Câmara J, Chakravarthy V, Perry A, Wood M, Dietz R, Wang J, De Los Reyes K, Raghavan R. Treatment of IgG4-related pachymeningitis in a patient with steroid intolerance: The role of early use of rituximab. Journal of Neuroimmunology 2016;299:62-5. [DOI: 10.1016/j.jneuroim.2016.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
89 Moskalik A, Kercher M, Vitt J, Lee H, Waldau B. Chiari decompression for syringomyelia in the setting of IgG4-related hypertrophic pachymeningitis: A case-based update. Neurochirurgie 2022. [DOI: 10.1016/j.neuchi.2022.02.007] [Reference Citation Analysis]
90 Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181:191-206. [PMID: 25865251 DOI: 10.1111/cei.12641] [Cited by in Crossref: 114] [Cited by in F6Publishing: 99] [Article Influence: 16.3] [Reference Citation Analysis]
91 Abdelrazek M, Stone JH. Neurologic Features of Immunoglobulin G4–Related Disease. Rheumatic Disease Clinics of North America 2017;43:621-31. [DOI: 10.1016/j.rdc.2017.06.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
92 Melenotte C, Seguier J, Ebbo M, Kaphan E, Bernit E, Saillier L, Audoin B, Feyeux D, Daniel L, Roche P, Graillon T, Dufour H, Boutière C, Girard N, Closs-prophette F, Guillaud C, Tieulié N, Regent A, Harlé JR, Hamidou M, Mekinian A, Grados A, Schleinitz N. Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review. Seminars in Arthritis and Rheumatism 2019;49:430-7. [DOI: 10.1016/j.semarthrit.2019.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
93 González-Moreno J, Losada López I, Ortego Centeno N. [IgG4-related disease]. Med Clin (Barc) 2015;145:539-44. [PMID: 25726306 DOI: 10.1016/j.medcli.2014.12.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Abe Y, Narita K, Kobayashi H, Kitadate A, Takeuchi M, Kikuchi Y, Ouchi T, Takeuchi K, Matsue K. Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphoma. Ann Hematol 2018;97:2345-52. [DOI: 10.1007/s00277-018-3481-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
95 Wu CS, Wang HP, Sung SF. Idiopathic hypertrophic pachymeningitis with anticardiolipin antibody: A case report. Medicine (Baltimore) 2021;100:e24387. [PMID: 33466222 DOI: 10.1097/MD.0000000000024387] [Reference Citation Analysis]
96 Han F, Zhong DR, Hao HL, Kong WZ, Zhu YC, Guan HZ, Cui LY. Cranial and lumbosacral hypertrophic pachymeningitis associated with systemic lupus erythematosus: A case report. Medicine (Baltimore) 2016;95:e4737. [PMID: 27684799 DOI: 10.1097/MD.0000000000004737] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
97 Woo PYM, Ng BCF, Wong JHM, Ng OKS, Chan TSK, Kwok NF, Chan KY. The protean manifestations of central nervous system IgG4-related hypertrophic pachymeningitis: a report of two cases. Chin Neurosurg J 2021;7:13. [PMID: 33536053 DOI: 10.1186/s41016-021-00233-5] [Reference Citation Analysis]
98 AbdelRazek MA, Venna N, Stone JH. IgG4-related disease of the central and peripheral nervous systems. Lancet Neurol 2018;17:183-92. [PMID: 29413316 DOI: 10.1016/S1474-4422(17)30471-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 9.3] [Reference Citation Analysis]
99 Bledsoe JR, Della-Torre E, Rovati L, Deshpande V. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS 2018;126:459-76. [PMID: 29924455 DOI: 10.1111/apm.12845] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 12.0] [Reference Citation Analysis]
100 Detlefsen S. Die IgG4-assoziierte Erkrankung: Mikroskopische Diagnose und Differenzialdiagnose. Pathologe 2019;40:619-26. [DOI: 10.1007/s00292-019-00685-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
101 Cação G, Calejo M, Alves JE, Medeiros PB, Vila-Cha N, Mendonça T, Taipa R, Silva AM, Damásio J. Clinical features of hypertrophic pachymeningitis in a center survey. Neurol Sci 2019;40:543-51. [PMID: 30588552 DOI: 10.1007/s10072-018-3689-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
102 Dziedzic T, Wojciechowski J, Nowak A, Marchel A. Hypertrophic pachymeningitis. Childs Nerv Syst 2015;31:1025-31. [PMID: 25771924 DOI: 10.1007/s00381-015-2680-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
103 Vasaitis L. IgG4-related disease: A relatively new concept for clinicians. Eur J Intern Med. 2016;27:1-9. [PMID: 26481243 DOI: 10.1016/j.ejim.2015.09.022] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
104 Detlefsen S, Klöppel G. Histopathologie der IgG4-RD. Z Rheumatol 2016;75:666-74. [DOI: 10.1007/s00393-016-0130-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
105 Tang R, Li F, Chen Q. A case report of atypical long segmental thoracic hypertrophic pachymeningitis with ossification of ligamentum flavum and literature review. Eur Spine J 2017;26:202-6. [PMID: 28365857 DOI: 10.1007/s00586-017-5030-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
106 Lyndon D, Lansley JA, Evanson J, Krishnan AS. Dural masses: meningiomas and their mimics. Insights Imaging 2019;10:11. [PMID: 30725238 DOI: 10.1186/s13244-019-0697-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
107 Kashii S. IgG4-Related Disease: A Neuro-Ophthalmological Perspective. Journal of Neuro-Ophthalmology 2014;34:400-7. [DOI: 10.1097/wno.0000000000000193] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
108 Fain O, Mekinian A. Les pachyméningites. La Revue de Médecine Interne 2017;38:585-91. [DOI: 10.1016/j.revmed.2017.03.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
109 Park BJ, Starks R, Kirby P, Menezes AH, Dlouhy BJ. IgG4-Related Disease of the Craniovertebral Junction. World Neurosurgery 2020;134:264-71. [DOI: 10.1016/j.wneu.2019.10.195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A, Baldissera E, Dagna L, Praderio L, Scotti R, Tresoldi M, Roveri L, Mariani A, Balzano G, Castoldi R, Doglioni C, Sabbadini MG, Della-Torre E. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45:135-145. [PMID: 26398142 DOI: 10.3109/03009742.2015.1055796] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
111 Budhram A, Gabril MY, Lee DH, Fraser JA. Hypertrophic Pachymeningitis With Optic Neuropathy Heralding Systemic Vasculitis. Can J Neurol Sci 2017;44:105-7. [DOI: 10.1017/cjn.2016.51] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]